VA Expands Access to Amyloidosis Treatment

Mar 27, 2020

Nuclear Cardiology and Cardiac CT for Fellows in Training - CANCELED

Read more

Mar 26, 2020

On-Demand COVID-19 Preparedness Webinar

Read more

Feb 22, 2020

Amyloidosis Symposium at Washington University in St. Louis

Read more

Inhaled xenon modulates microglia and ameliorates disease in mouse models of amyloidosis and tauopathy

Read more

Amyloidosis Support Groups Webinar on Cardiac Amyloidosis

Read more

AstraZeneca advances scientific leadership in haematology at ASH 2023

Read more

International Symposium on Amyloidosis

Read more

Amyloidosis Foundation: Nashville Support Group Meeting

Read more

A vision toward a more holistic approach to care in hereditary ATTR amyloidosis

Read more

Alnylam Announces Receipt of Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis

Read more

Subscribe to